BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia

Upregulation of BIM by PRED in acute lymphoblastic leukemia cells regardless of molecular subtype is significantly prognostic of outcomes, confirming BIM's essential regulatory role in the PRED-induced apoptosis.